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Abstract
Background: Myxofibrosarcoma is common in the extremities of elderly people and is characterized by a high 
frequency of local recurrence.
Case presentation: We report a 37 year old female who presented with a 4-month history of facial pain and a 3-month 
history of painful progressive swelling in the preauricular area. She underwent a total parotidectomy. The tumor was 
histopathologically and immunohistochemically diagnosed as a low-grade myxofibrosarcoma. The patient was free of 
disease 9 months after surgery with uneventful post-operative clinical course.
Conclusions: Parotid area swelling should always alert doctors. To our knowledge, this is the first case of parotid 
myxofibrosarcoma. It should be added to the differential diagnosis of diseases of the parotid. We have to recognize this 
disease and seek adequate treatment for it.
Background
Myxofibrosarcoma is a fibroblast-derived sarcoma with
character of myxoid areas in association with varying
proportions of cellular areas showing a pleomorphic sto-
riform pattern. It grows commonly in the subcutaneous
of the extremities of elderly people, with rare occurrences
in the head and neck (2.7%) [1].
Here we report a case of low-grade myxofibrosarcoma,
arising in the parotid, and review the clinical, radiological
and histopathological characteristics of this neoplasm. To
our knowledge, such a presentation of parotid myxofibro-
sarcoma has not been reported before.
Case presentation
A 37-year-old woman presented with a 4-month history
of right facial pain and a 3-month history of progressive
painful swelling beneath the right ear lobe. Examination
revealed a soft swelling in the anteroinferior auricular
area. The mass was smooth, elastic, mobile and painful
on pressure, not fluctuant. The facial nerve function was
normal. The cervical lymph node was not palpable. There
were no systemic symptoms. The patient was screened
for metastases, and no lung or abdomen lesion was
detected. Sonography revealed solid echo in right parotid
gland and cervical lymph node swelling. A contrast
enhanced CT scan revealed a well defined soft tissue
mass in right deep parotid lobe (Figure 1).
The standard parotidectomy was performed. A 10 mm
× 10 mm superior deep lateral cervical lymph node was
resected simultaneously. The rapid intraoperative patho-
logical diagnosis showed the samples from the mass low-
grade malignancy and no metastases in the lymph node.
Therefore the mass was removed with surgical margin of
1 cm radius around it and preservation of the facial nerve.
The surgical margin was microscopically free of tumor. A
closed vacuum drainage system was used.
Macroscopically, the tumor was a grayish-red collage-
nous mass intermingled with myxoid. Main stem of the
facial nerve and the sternocleidomastoid muscle were
involved (Figure 2). The excised specimen measured 60
mm × 25 mm × 30 mm.
Microscopically, the tumor was fairly well circum-
scribed but not encapsulated perfectly. It consisted of
hypocellular to moderately cellular myxoid or fibromyx-
oid areas. Curvilinear capillaries with perivascular cell
condensation were found. Fusiform tumor cells vary from
small and bland to enlarged, bizarre, pleomorphic and
multinucleated. The cytoplasm of the cells was scant and
slightly eosinophilic, and mitoses were infrequent (Figure
3).
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Page 2 of 4Immunohistochemical studies showed that the tumor
cells expressed strong immunoreactivity for vimentin
(VIM) and alpha1-antichymotrypsin (α1-ACT). Labeling
index of Ki-67 (the number of Ki67 positive tumor cells
divided by the sum of Ki67 positive and negative tumor
cells) was 35% (Figure 4). Desmin (DES), alpha-smooth
muscle actin (α-SMA), beta2-microglobulin (β2-MG) and
cluster of differentiation 34 (CD34) assays were negative
(Figure 5).
Pathology revealed a T3N0M0 (AJCC 2002) parotid
myxofibrosarcoma of low histological grade.
The patient's post-operative clinical course was
uneventful. She was discharged on the six post-operative
days. The right parotid received the full dose of radiation
(68.4 Gy). The patient was free of disease 8 months after
surgery.
Conclusions
Myxofibrosarcoma (MFS), one of soft tissue sarcomas
with complex genomic profiles, shows gains and losses of
numerous chromosomes or chromosome regions [2].
MFS was described firstly by Angervall as a group of
Figure 1 CT scan of the patient. A contrast enhanced Computed to-
mography (CT) scan revealed a well defined soft tissue mass (40 mm × 
25 mm, arrow) in the right deep parotid lobe.
Figure 2 Relationship between tumor and facial nerve represent-
ed during surgery. The tumor was a grayish-red collagenous mass 
(black arrow). Main stem of the facial nerve (yellow arrow) was in-
volved.
Figure 3 Photomicrograph of the tumor (H&E; ×100). Myxoid areas 
in association with spindle cells showing a pleomorphic storiform pat-
tern as seen.
Figure 4 Positive immunohistochemical findings (immunoperox-
idase technique; ×200). The tumor cells are positive for ACT (a) and 
VIM (b). Labeling index of Ki-67 (c) is 35%.
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Page 3 of 4fibroblastic lesions which has cellular distribution, pleo-
morphism of the nucleus, and mitotic activity that varies
from a less cellular lesion with minimal cytologic atypia
to a more cellular lesion [3]. As the commonest sarcoma
affecting limbs of older patients [1,3-5], high-grade (HG)
lesions of MFS were considered to be a myxoid variant of
malignant fibrous histiocytomas (MFH) by some investi-
gators [6,7], which was historically classified as a myxoid
variant of MFH [8]. However, myxofibrosarcoma is now
believed by many authors to be a clinically distinct entity
[1,8,9]. They advocated naming it MFS instead of myxoid
MFH. This is ascribed to the myxoid nodular appearance,
characteristic curvilinear vasculatures, nuclear pleomor-
phism, histochemical staining, ultrastructural features
and its clinicopathologic features [1,4,5,10,11].
According to the study of Antonescu CR and Baren A,
basing on microscopic analysis, immunohistostaining by
S100 and ultrastructural analysis will help us with the dif-
ferential diagnosis between myxofibrosarcoma and fibro-
myxoid sarcoma [12]. Unfortunately, the latter two
studies were not performed in this case. While micro-
scopically, the spindled tumor cells, hyperchromatic and
irregular nuclei, variable pleomorphism, scattered multi-
nucleated or giant tumor cells and curvilinear-type ves-
sels all verify the tumor is a myxofibrosarcoma instead of
a fibromyxoid sarcoma.
Basing on the degree of cellularity, pleomorphism of
the nucleus and mitotic activity, myxofibrosarcoma has
been divided into three [1,8] or four [1,4,8] grades. Low-
grade myxofibrosarcoma has low malignancy with rare
distant metastasis and high local recurrence rate (50-
60%) [1,4,13], which is similar with that of the high-grade
type. Sufficient surgical treatment is the most necessary
to suppress local recurrence.
Myxofibrosarcoma is one of the commonest sarcomas
of the elder's extremities. It often grows slowly and pain-
lessly with almost equal incidence of men and women. In
our case, the patient was just 37-year old, which makes it
special. What's more, majority of the tumors are located
in the subcutaneous tissue and form multiple gelatinous
nodules, which tend to spread in a longitudinal manner.
In the head and neck region, myxofibrosarcoma is
uncommon. We found some case reports of myxofibro-
sarcoma in this region, such as in sphenoid sinus, maxil-
lary sinus, hypopharynx, mandible and neck [14-18].
There are also some reports of parotid sarcomas, such as
sclerosing rhabdomyosarcoma, synovial sarcoma and
interdigitating dendritic cell sarcoma (IDCS), but no
myxofibrosarcoma [19-21].
Parotid area swelling should always alert doctors. A
unilateral swelling of the parotid implicates a possibility
of a rare malignant myxofibrosarcoma. To our knowl-
edge, this is the first case of parotid myxofibrosarcoma. It
should be added to the differential diagnosis of diseases
of the parotid. We have to recognize this disease and seek
adequate treatment for it.
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Figure 5 Negative immunohistochemical findings (immunoper-
oxidase technique; ×200). The tumor cells are negative for CD34 (a), 
DES (b), MG (c) and SMA (d).
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